By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Identification, development and commercialization of medicines for childhood and adult diseases with39.8M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States131.16M100.00%